The Vitamin D Receptor Genotype Predisposes to the Development of Calcific Aortic Valve Stenosis

Overview

Journal Heart

Date 2001 May 23

PMID 11359741

Citations 37

Authors

J R Ortlepp

R Hoffmann

F Ohme

J Lauscher

F Bleckmann

P Hanrath

Affiliations

Soon will be listed here.

Abstract

Objective: To test the hypothesis that vitamin D receptor polymorphism is associated with calcific aortic valve stenosis.

Design: The distribution of one polymorphism of the vitamin D receptor (BsmI B/b) was examined in 100 consecutive patients with calcific valvar aortic stenosis and compared with a control group of 100 patients (paired match for age, sex, and the presence of coronary artery disease from a total of 630 patients without calcified aortic valves). Polymerase chain reaction and restriction fragment length polymorphism were used to determine genotypes.

Results: There was a significant difference in vitamin D receptor allele and genotype frequencies between the two groups. The allele B had a higher prevalence in patients with calcific aortic stenosis (B = 0.56, b = 0.44) than in the control cohort (B = 0.40, b = 0.60) (p = 0.001).

Conclusions: There is a significant association of vitamin D receptor polymorphism with calcific aortic valve stenosis. The B allele of the vitamin D receptor is more common in patients with calcific aortic valve stenosis. It now needs to be evaluated whether other genes that control calcium homeostasis are involved in the pathogenesis of this disorder.

Citing Articles

Genetics of Calcific Aortic Stenosis: A Systematic Review.

Vassiliou V, Johnson N, Langlands K, Tsampasian V Genes (Basel). 2024; 15(10).

PMID: 39457433 PMC: 11508093. DOI: 10.3390/genes15101309.

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.

Nardin M, Verdoia M, Nardin S, Cao D, Chiarito M, Kedhi E Biomedicines. 2024; 12(4).

PMID: 38672124 PMC: 11048686. DOI: 10.3390/biomedicines12040768.

Increasing baseline aortic valve peak flow velocity is associated with progression of aortic valve stenosis in osteoporosis patients-a possible link to low vitamin D status.

Tsuruda T, Funamoto T, Suzuki C, Yamamura Y, Nakai M, Chosa E Arch Osteoporos. 2023; 18(1):129.

PMID: 37874407 PMC: 10598115. DOI: 10.1007/s11657-023-01339-2.

Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.

Di Costanzo A, Indolfi C, Franzone A, Esposito G, Spaccarotella C Int J Mol Sci. 2023; 24(19).

PMID: 37834387 PMC: 10573862. DOI: 10.3390/ijms241914939.

Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus.

Wal P, Rathore S, Aziz N, Singh Y, Gupta A Egypt Heart J. 2023; 75(1):26.

PMID: 37027109 PMC: 10082141. DOI: 10.1186/s43044-023-00345-6.

References

Passik C, Ackermann D, Pluth J, Edwards W . Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. 1987; 62(2):119-23. DOI: 10.1016/s0025-6196(12)61880-1. View

Morrison N, Yeoman R, Kelly P, Eisman J . Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A. 1992; 89(15):6665-9. PMC: 49563. DOI: 10.1073/pnas.89.15.6665. View

Morrison N, Qi J, Tokita A, Kelly P, Crofts L, Nguyen T . Prediction of bone density from vitamin D receptor alleles. Nature. 1994; 367(6460):284-7. DOI: 10.1038/367284a0. View

Otto C, Kuusisto J, REICHENBACH D, Gown A, OBrien K . Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994; 90(2):844-53. DOI: 10.1161/01.cir.90.2.844. View

Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman J, Bonjour J . Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet. 1995; 345(8947):423-4. DOI: 10.1016/s0140-6736(95)90404-2. View

Dawson-Hughes B, Harris S, Finneran S . Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab. 1995; 80(12):3657-61. DOI: 10.1210/jcem.80.12.8530616. View

Houston L, Grant S, Reid D, Ralston S . Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone. 1996; 18(3):249-52. DOI: 10.1016/8756-3282(95)00483-1. View

Garnero P, Borel O, Sornay-Rendu E, Arlot M, Delmas P . Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study. J Bone Miner Res. 1996; 11(6):827-34. DOI: 10.1002/jbmr.5650110614. View

Stewart B, Siscovick D, Lind B, Gardin J, Gottdiener J, Smith V . Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29(3):630-4. DOI: 10.1016/s0735-1097(96)00563-3. View

10.

Carabello B, Crawford Jr F . Valvular heart disease. N Engl J Med. 1997; 337(1):32-41. DOI: 10.1056/NEJM199707033370107. View

11.

Kiel D, Myers R, Cupples L, Kong X, Zhu X, Ordovas J . The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res. 1997; 12(7):1049-57. DOI: 10.1359/jbmr.1997.12.7.1049. View

12.

Iacoviello L, Di Castelnuovo A, de Knijff P, DOrazio A, Amore C, Arboretti R . Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med. 1998; 338(2):79-85. DOI: 10.1056/NEJM199801083380202. View

13.

Siffert W, Rosskopf D, SIFFERT G, Busch S, Moritz A, Erbel R . Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998; 18(1):45-8. DOI: 10.1038/ng0198-45. View

14.

Eccleshall T, Garnero P, Gross C, Delmas P, Feldman D . Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res. 1998; 13(1):31-5. DOI: 10.1359/jbmr.1998.13.1.31. View

15.

Willing M, Sowers M, Aron D, Clark M, Burns T, Bunten C . Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res. 1998; 13(4):695-705. DOI: 10.1359/jbmr.1998.13.4.695. View

16.

Kung A, Yeung S, Lau K . Vitamin D receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone. 1998; 22(4):389-93. DOI: 10.1016/s8756-3282(97)00301-3. View

17.

Hansen T, Abrahamsen B, Henriksen F, Hermann A, Jensen L, Horder M . Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone. 1998; 22(5):571-5. DOI: 10.1016/s8756-3282(98)00028-3. View

18.

Karkoszka H, Chudek J, Strzelczyk P, Wiecek A, Schmidt-Gayk H, Ritz E . Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients?. Nephrol Dial Transplant. 1998; 13(8):2077-80. DOI: 10.1093/ndt/13.8.2077. View

19.

Gong G, Stern H, Cheng S, Fong N, Mordeson J, Deng H . The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int. 1999; 9(1):55-64. DOI: 10.1007/s001980050116. View

20.

Ferrari S, Manen D, Bonjour J, Slosman D, Rizzoli R . Bone mineral mass and calcium and phosphate metabolism in young men: relationships with vitamin D receptor allelic polymorphisms. J Clin Endocrinol Metab. 1999; 84(6):2043-8. DOI: 10.1210/jcem.84.6.5790. View